Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
5,698.81
5,990.93
8,299.10
7,646.12
5,962.32
5,221.39
5,677.98
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,698.81
5,990.93
8,299.10
7,646.12
5,962.32
5,221.39
5,677.98
Raw Material Cost
3,926.23
4,139.61
5,718.93
5,342.29
3,759.35
3,392.79
3,523.91
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
359.16
326.86
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
166.42
263.76
299.12
262.38
307.42
315.61
269.42
Selling and Distribution Expenses
781.35
1,002.05
1,106.72
1,033.13
833.24
769.14
716.00
Other Expenses
5.44
-7.24
-1.50
-36.12
-46.12
-15.40
-5.52
Total Expenditure (Excl Depreciation)
4,928.43
5,332.98
7,109.73
6,635.75
4,765.71
4,323.50
4,454.17
Operating Profit (PBDIT) excl Other Income
770.4000000000001
658
1189.4
1010.4000000000001
1196.6
897.9000000000001
1223.8
Other Income
383.33
98.30
350.39
-101.14
-149.50
804.21
319.85
Operating Profit (PBDIT)
1,518.99
236.11
1,867.41
968.74
1,329.82
1,941.73
1,764.90
Interest
166.42
263.76
299.12
262.38
307.42
315.61
269.42
Exceptional Items
-41.39
-78.12
-118.75
76.99
555.61
138.38
-33.13
Gross Profit (PBDT)
1,772.57
1,851.33
2,580.16
2,303.84
2,202.97
1,828.61
2,154.08
Depreciation
370.02
425.06
370.03
370.46
345.50
294.08
269.38
Profit Before Tax
941.16
-530.82
1,079.52
412.89
1,232.50
1,470.42
1,192.97
Tax
109.84
-139.42
133.52
-13.40
344.08
307.72
158.66
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
701.21
-865.50
845.91
290.20
1,150.90
1,201.22
700.56
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
701.21
-865.50
845.91
290.20
1,150.90
1,201.22
700.56
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-23.66
-20.89
-14.41
-8.92
-2.90
-17.92
-27.52
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
677.55
-886.38
831.50
281.28
1,148.00
1,183.30
673.04
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.06
1.1
1.12
1.22
1.19
0.0
0.0
Reserves
12,928.76
13,116.44
13,824.01
13,959.12
13,717.14
8,219.84
6,954.67
Earnings per share (EPS)
0.48
-0.59
0.58
0.2
0.85
0.0
0.0
Diluted Earnings per share
0.48
-0.59
0.58
0.2
0.85
0.0
0.0
Operating Profit Margin (Excl OI)
13.44%
-4.79%
13.82%
9.15%
19.02%
16.15%
20.71%
Gross Profit Margin
23.01%
-1.77%
17.47%
10.25%
26.47%
33.79%
25.75%
PAT Margin
12.3%
-14.45%
10.19%
3.8%
19.3%
23.01%
12.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is -4.88% vs -27.81% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 176.44% vs -206.60% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 724.17% vs -90.92% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -36.92% vs -11.80% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
5,698.81
43.38
5,655.43
13,036.95%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,698.81
43.38
5,655.43
13,036.95%
Raw Material Cost
3,926.23
94.63
3,831.60
4,049.03%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
431.23
-431.23
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
166.42
20.69
145.73
704.35%
Selling and Distribution Expenses
781.35
261.58
519.77
198.70%
Other Expenses
5.44
20.68
-15.24
-73.69%
Total Expenditure (Excl Depreciation)
4,928.43
1,014.92
3,913.51
385.60%
Operating Profit (PBDIT) excl Other Income
770.37
-971.54
1,741.91
179.29%
Other Income
383.33
-32.75
416.08
1,270.47%
Operating Profit (PBDIT)
1,518.99
-2,850.21
4,369.20
153.29%
Interest
166.42
20.69
145.73
704.35%
Exceptional Items
-41.39
2,795.85
-2,837.24
-101.48%
Gross Profit (PBDT)
1,772.57
-51.25
1,823.82
3,558.67%
Depreciation
370.02
78.04
291.98
374.14%
Profit Before Tax
941.16
-153.09
1,094.25
714.78%
Tax
109.84
0.00
109.84
Provisions and contingencies
0
0
0.00
Profit After Tax
701.21
-153.09
854.30
558.04%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
701.21
-153.09
854.30
558.04%
Share in Profit of Associates
0
0
0.00
Minority Interest
-23.66
0.00
-23.66
Other related items
0.00
0.00
0.00
Consolidated Net Profit
677.55
-153.09
830.64
542.58%
Equity Capital
0
0
0.00
Face Value
1.06
0.00
0.00
Reserves
12,928.76
-806.85
13,735.61
1,702.37%
Earnings per share (EPS)
0.48
-0.12
0.60
500.00%
Diluted Earnings per share
0.48
-0.12
0.60
500.00%
Operating Profit Margin (Excl OI)
13.44%
-6,675.25%
0.00
6,688.69%
Gross Profit Margin
23.01%
-173.01%
0.00
196.02%
PAT Margin
12.30%
-352.92%
0.00
365.22%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 569.88 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -4.88% vs -27.81% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 67.76 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 176.44% vs -206.60% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 113.57 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 724.17% vs -90.92% in Dec 2023
Annual - Interest
Interest 16.64 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -36.92% vs -11.80% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.44%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
